JPH0379990B2 - - Google Patents
Info
- Publication number
- JPH0379990B2 JPH0379990B2 JP58120594A JP12059483A JPH0379990B2 JP H0379990 B2 JPH0379990 B2 JP H0379990B2 JP 58120594 A JP58120594 A JP 58120594A JP 12059483 A JP12059483 A JP 12059483A JP H0379990 B2 JPH0379990 B2 JP H0379990B2
- Authority
- JP
- Japan
- Prior art keywords
- alanine
- acid
- solution
- crystals
- aspartic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229960003767 alanine Drugs 0.000 claims description 54
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 53
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 claims description 51
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 claims description 51
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical class OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 47
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical class OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 34
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical class OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 29
- 229960005261 aspartic acid Drugs 0.000 claims description 27
- 239000013078 crystal Substances 0.000 claims description 25
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Chemical class OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims description 24
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Chemical class OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims description 24
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 24
- 239000001530 fumaric acid Substances 0.000 claims description 23
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Chemical class OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 18
- 235000011090 malic acid Nutrition 0.000 claims description 18
- 229940116298 l- malic acid Drugs 0.000 claims description 16
- 229910052783 alkali metal Inorganic materials 0.000 claims description 12
- 150000001340 alkali metals Chemical class 0.000 claims description 9
- 239000012535 impurity Substances 0.000 claims description 9
- 229960002598 fumaric acid Drugs 0.000 claims description 7
- 150000003863 ammonium salts Chemical class 0.000 claims description 6
- 239000000243 solution Substances 0.000 description 36
- 238000000034 method Methods 0.000 description 23
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 22
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 14
- 238000006911 enzymatic reaction Methods 0.000 description 13
- 230000000694 effects Effects 0.000 description 11
- 244000005700 microbiome Species 0.000 description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 229910021529 ammonia Inorganic materials 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000002425 crystallisation Methods 0.000 description 6
- 230000008025 crystallization Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 5
- 108700016171 Aspartate ammonia-lyases Proteins 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 5
- -1 alkali metal bicarbonate Chemical class 0.000 description 5
- 239000001099 ammonium carbonate Substances 0.000 description 5
- 235000012501 ammonium carbonate Nutrition 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 241001022577 Dacne Species 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- 241000589516 Pseudomonas Species 0.000 description 4
- 239000000679 carrageenan Substances 0.000 description 4
- 235000010418 carrageenan Nutrition 0.000 description 4
- 229920001525 carrageenan Polymers 0.000 description 4
- 229940113118 carrageenan Drugs 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 235000004279 alanine Nutrition 0.000 description 3
- 235000019297 ammonium fumarate Nutrition 0.000 description 3
- 235000003704 aspartic acid Nutrition 0.000 description 3
- CKKXWJDFFQPBQL-SEPHDYHBSA-N azane;(e)-but-2-enedioic acid Chemical compound N.N.OC(=O)\C=C\C(O)=O CKKXWJDFFQPBQL-SEPHDYHBSA-N 0.000 description 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 3
- 239000000110 cooling liquid Substances 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000002510 pyrogen Substances 0.000 description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- 239000001729 Ammonium fumarate Substances 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 229940099690 malic acid Drugs 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 2
- 235000019295 potassium fumarate Nutrition 0.000 description 2
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- OHFNOQQJKQDEOT-UHFFFAOYSA-N 3-(3-methylphenyl)piperidine Chemical compound CC1=CC=CC(C2CNCCC2)=C1 OHFNOQQJKQDEOT-UHFFFAOYSA-N 0.000 description 1
- 108010036781 Fumarate Hydratase Proteins 0.000 description 1
- 102100036160 Fumarate hydratase, mitochondrial Human genes 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- 125000003412 L-alanyl group Chemical group [H]N([H])[C@@](C([H])([H])[H])(C(=O)[*])[H] 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000001747 Potassium fumarate Substances 0.000 description 1
- 239000001744 Sodium fumarate Substances 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 150000001339 alkali metal compounds Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000001649 capillary isotachophoresis Methods 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- YKZPPPNXRZHVGX-PXYKVGKMSA-L dipotassium;(2s)-2-aminobutanedioate;hydron;hydrate Chemical compound [H+].[H+].O.[K+].[K+].[O-]C(=O)[C@@H](N)CC([O-])=O.[O-]C(=O)[C@@H](N)CC([O-])=O YKZPPPNXRZHVGX-PXYKVGKMSA-L 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- MSJMDZAOKORVFC-SEPHDYHBSA-L disodium fumarate Chemical compound [Na+].[Na+].[O-]C(=O)\C=C\C([O-])=O MSJMDZAOKORVFC-SEPHDYHBSA-L 0.000 description 1
- XMXOIHIZTOVVFB-JIZZDEOASA-L disodium;(2s)-2-aminobutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CC([O-])=O XMXOIHIZTOVVFB-JIZZDEOASA-L 0.000 description 1
- 229940050411 fumarate Drugs 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- RSAZYXZUJROYKR-UHFFFAOYSA-N indophenol Chemical compound C1=CC(O)=CC=C1N=C1C=CC(=O)C=C1 RSAZYXZUJROYKR-UHFFFAOYSA-N 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229940111688 monobasic potassium phosphate Drugs 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229940068988 potassium aspartate Drugs 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- SHPKCSFVQGSAJU-SEPHDYHBSA-L potassium fumarate Chemical compound [K+].[K+].[O-]C(=O)\C=C\C([O-])=O SHPKCSFVQGSAJU-SEPHDYHBSA-L 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 1
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 1
- 229960001327 pyridoxal phosphate Drugs 0.000 description 1
- 230000001698 pyrogenic effect Effects 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 235000019294 sodium fumarate Nutrition 0.000 description 1
- 229940005573 sodium fumarate Drugs 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Description
ãçºæã®è©³çŽ°ãªèª¬æã
æ¬çºæã¯ïŒ¬âã¢ã©ãã³çµæ¶ã®ååŸæ¹æ³ã«é¢ãã
æŽã«è©³ããã¯ã借éç©ãšããŠããã«é
žãâãªã³
ãŽé
žåã³ïŒ¬âã¢ã¹ãã©ã®ã³é
žã®åã¢ã³ã¢ããŠã å¡©
ãå«æããç²ïŒ¬âã¢ã©ãã³æº¶æ¶²ããã簡䟿ãªæ段
ã§é«çŽåºŠïŒ¬âã¢ã©ãã³çµæ¶ãååŸããæ¹æ³ã«é¢ã
ããDETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for obtaining L-alanine crystals,
More specifically, the present invention relates to a method for obtaining high-purity L-alanine crystals by a simple means from a crude L-alanine solution containing ammonium salts of fumaric acid, L-malic acid, and L-aspartic acid as contaminants.
âã¢ã©ãã³ã®å·¥æ¥ç補æ³ãšããŠã¯ãããã«é
ž
ãšã¢ã³ã¢ãã¢ãåºçºåæãšããŠãã¢ã¹ãã«ã¿ãŒãŒ
掻æ§ãæãã埮çç©ãçšããŠïŒ¬âã¢ã¹ãã©ã®ã³é
ž
ã補é ããåŸãåã¯åæã«ïŒ¬âã¢ã¹ãã©ã®ã³é
žâ
βâãã«ã«ããã·ã©ãŒãŒæŽ»æ§ãæãã埮çç©ãçš
ããŠïŒ¬âã¢ã©ãã³ã補é ããæ¹æ³ãç¥ãããŠã
ãããã®æ¹æ³ã¯ïŒ¬âã¢ã¹ãã©ã®ã³é
žã®æ¶æåé¢æ
äœãçç¥ã§ãããªã©ã®ç¹ããå¹çã®è¯ãæ¹æ³ãšã
ãããŠãããæŽã«æè¿ã§ã¯äžèšé
µçŽ åå¿ãåºå®å
埮çç©ãçšããŠè¡ãªããšã埮çç©èäœã®å¹é€åæ
ããã³çš®ã
ã®ã¿ã³ãã¯è³ªãªã©ã®äžçŽç©ãé
µçŽ åå¿
çµäºæ¶²äžã«å«ãŸããŠããããã®ãã該é
µçŽ åå¿çµ
äºæ¶²ããå¹çããâã¢ã©ãã³ãåŸãããããšã
ç¥ãããŠããããã®æ§ã«åºå®å埮çç©ãçšãã
âã¢ã©ãã³ã®è£œæ³ã¯åªããæ¹æ³ã§ããããäžèšã¢
ã¹ãã«ã¿ãŒãŒæŽ»æ§ãæãã埮çç©ã¯ããã©ãŒãŒæŽ»
æ§ãåæã«æããŠããããããããçšããé
µçŽ å
å¿ã«ãããŠã¯ãããã«é
žããâãªã³ãŽé
žãžã®è»¢
æåå¿ãåæã«èµ·ããããŸããããã«é
žããâ
ã¢ã¹ãã©ã®ã³é
žã補é ããåå¿ã«ã¯åå¿å¹³è¡¡ãã
ããåºçºåæã®ããã«é
žãæ®åããããšã«ãªãã
æŽã«ïŒ¬âã¢ã¹ãã©ã®ã³é
žããâã¢ã©ãã³ã補é
ããåå¿ã«ãããŠãâã¢ã¹ãã©ã®ã³é
žã100ïŒ
åå¿ãããããšã¯ã§ãããâã¢ã¹ãã©ã®ã³é
žã
æ®åããããã該åå¿ã«ãããŠã¯äºé
žåççŽ ãå¯
çãããããåæã®ã¢ã³ã¢ãã¢ãšåå¿ãçé
žã¢ã³
ã¢ããŠã ãçæãããããªãã¡ãåèšã®åºå®å埮
çç©ãçšããâã¢ã©ãã³ã®è£œé æ¹æ³ã«ãããŠ
ãã該é
µçŽ åå¿çµäºæ¶²äžã«ã¯ç®çç©ïŒ¬âã¢ã©ãã³
ã®ä»ã«ãããã«é
žãâãªã³ãŽé
žãâã¢ã¹ãã©
ã®ã³é
žïŒãããã®é
žã¯åŒ·é
žã§ãããããã®ã¢ã³ã¢
ããŠã å¡©ã®åœ¢ã§ïŒããçé
žã¢ã³ã¢ããŠã ãªã©ã®å€Ÿ
éç©ãå«ãŸããŠããããã®ããåŸæ¥ããã®æ§ãªå€Ÿ
éç©ãå«æããâã¢ã©ãã³æº¶æ¶²ãããé«çŽåºŠã®
âã¢ã©ãã³çµæ¶ãåŸãæ¹æ³ãšããŠã¯ã該溶液ã
ã€ãªã³äº€ææš¹èã§åŠçããâã¢ã©ãã³çžåœåºå
ãåç»ããåŸãæ¿çž®ãæ¶æãè¡ãªããããããã¯
äžæŠç²ïŒ¬âã¢ã©ãã³çµæ¶ãšããŠåé¢ããåŸãåçµ
æ¶ãè¡ããªã©ã®ç
©éãªç²Ÿè£œåé¢æäœãå¿
èŠãšããŠ
ãããå·¥æ¥çã«ã¯å¿
ãããæºè¶³ããããã®ã§ã¯ãª
ãã€ãã An industrial method for producing L-alanine is to produce L-aspartic acid using fumaric acid and ammonia as starting materials using a microorganism having aspartase activity, or simultaneously to produce L-aspartic acid.
A method for producing L-alanine using microorganisms having β-decarboxylase activity is known, and this method is said to be efficient because it can omit the crystallization and separation operation of L-aspartic acid. There is. Furthermore, recently, when the above enzymatic reaction is carried out using immobilized microorganisms, impurities such as the culture materials of microbial cells and various proteins are not contained in the enzyme reaction finished solution, and therefore, the enzyme reaction finished solution is efficiently extracted. It is known that L-alanine can be obtained. L using immobilized microorganisms in this way
-Although the method for producing alanine is an excellent method, since the above-mentioned microorganisms that have aspartase activity also have fumarase activity, the enzymatic reaction using this microorganism also involves the conversion reaction of fumaric acid to L-malic acid. occur at the same time. Also, from fumaric acid to L-
There is a reaction equilibrium in the reaction to produce aspartic acid, and the starting material, fumaric acid, remains.
Furthermore, in the reaction to produce L-alanine from L-aspartic acid, 100% L-aspartic acid is used.
The reaction cannot be carried out, and L-aspartic acid remains, and in addition, carbon dioxide is produced as a by-product in the reaction, and this reacts with the raw material ammonia to produce ammonium carbonate. That is, even in the method for producing L-alanine using the above-mentioned immobilized microorganism, the enzyme reaction finished solution contains fumaric acid, L-malic acid, L-aspartic acid (these Since the acid is a strong acid, it contains impurities such as its ammonium salt (in the form of its ammonium salt) and ammonium carbonate. For this reason, the conventional method for obtaining high-purity L-alanine crystals from an L-alanine solution containing such impurities was to treat the solution with an ion exchange resin and fractionate the fraction corresponding to L-alanine. This method requires complicated purification and separation operations, such as subsequent concentration and crystallization, or once separated as crude L-alanine crystals and then recrystallization, which is not necessarily satisfactory from an industrial perspective. .
æ¬çºæè
ãã¯äžèšèª²é¡ã«é¢ãéæç 究ããçµ
æãäžèšã®åŠãã借éç©ãšããŠããã«é
žãâãª
ã³ãŽé
žãåã³ïŒ¬âã¢ã¹ãã©ã®ã³é
žã®åã¢ã³ã¢ããŠ
ã å¡©ãå«æããç²ïŒ¬âã¢ã©ãã³æº¶æ¶²ããâã¢ã©
ãã³çµæ¶ãååŸããã«éãã該ç²ïŒ¬âã¢ã©ãã³æº¶
液äžã«ã¢ã«ã«ãªéå±ãååšãããããšã«ãããç°¡
䟿ãªæäœã§ïŒ¬âã¢ã©ãã³é«çŽåºŠçµæ¶ãé«åçã§å
åŸã§ããããšãèŠãåºãæ¬çºæãå®æãããããª
ãã¡ãæ¬çºæã¯ãããã«é
žãâãªã³ãŽé
žãåã³
âã¢ã¹ãã©ã®ã³é
žã®åã¢ã³ã¢ããŠã å¡©ã借éç©
ãšããŠå«æããç²ïŒ¬âã¢ã©ãã³æº¶æ¶²ããâã¢ã©
ãã³çµæ¶ãååŸããã«éãã該ç²ïŒ¬âã¢ã©ãã³æº¶
液äžã«å
±åããããã«é
žãâãªã³ãŽé
žãåã³ïŒ¬
âã¢ã¹ãã©ã®ã³é
žã®ç·éã«å¯ŸãçŽ0.5ã1.5åœéã®
ã¢ã«ã«ãªéå±ãååšãããŠæ¿çž®ããåŸãæ¶æãè¡
ãããšãç¹åŸŽãšããâã¢ã©ãã³çµæ¶ã®ååŸæ¹æ³
ã§ããã As a result of intensive research into the above problem, the present inventors found that L-alanine crystals were obtained from a crude L-alanine solution containing ammonium salts of fumaric acid, L-malic acid, and L-aspartic acid as impurities. When obtaining L-alanine, the present invention was completed based on the discovery that by adding an alkali metal to the crude L-alanine solution, high-purity crystals of L-alanine can be obtained in high yield with a simple operation. That is, the present invention provides a method for obtaining L-alanine crystals from a crude L-alanine solution containing ammonium salts of fumaric acid, L-malic acid, and L-aspartic acid as impurities. Fumaric acid, L-malic acid, and L-malic acid coexisting in
- A method for obtaining L-alanine crystals, which comprises performing crystallization after concentration in the presence of about 0.5 to 1.5 equivalents of alkali metal based on the total amount of aspartic acid.
æ¬çºæã«çšããç²ïŒ¬âã¢ã©ãã³æº¶æ¶²ã¯äŸãã°å
èšããåŠããããã«é
žãšã¢ã³ã¢ãã¢ãåºè³ªãšããŠ
åºå®åé
µçŽ åå¿ãããå
¬ç¥ã®æ¹æ³ã«ããåŸãããš
ãã§ãããäŸãã°ãã¢ã¹ãã«ã¿ãŒãŒæŽ»æ§ãæãã
埮çç©èäœãããã¯ãã®åŠçç©ããã³ïŒ¬âã¢ã¹ã
ã©ã®ã³é
žâβâãã«ã«ããã·ã©ãŒãŒæŽ»æ§ãæãã
埮çç©èäœãããã¯ãã®åŠçç©ãããããå
¬ç¥ã®
æ¹æ³ïŒäŸãã°ã«ã©ã®ãŒãã³ã²ã«å
æ¬æ³ãããªã¢ã¯
ãªã«ã¢ããã²ã«å
æ¬æ³ãªã©ïŒã§åºå®åããŠåŸãã
ãåºå®åç©ãçšããŠé
µçŽ åå¿ãããããšã«ãã容
æã«è£œé ããããšãã§ãããã¢ã¹ãã«ã¿ãŒãŒæŽ»æ§
ãæãã埮çç©ãšããŠã¯è©²æŽ»æ§ãæãããã®ã§ã
ãã°ããããçšããããšãã§ãäŸãã°ãšã·ãšãªã·
ã¢ã»ã³ãªïŒATCCâ11303ïŒããåâã¢ã¹ãã©
ã®ã³é
žâβâãã«ã«ããã·ã©ãŒãŒæŽ»æ§ãæãã埮
çç©ãšããŠã¯è©²æŽ»æ§ãæãããã®ã§ããã°ããã
ãçšããããšãã§ãäŸãã°ã·ãŠãŒãã¢ãã¹ã»ãã¯
ããŒïŒIAMâ1152ïŒã奜é©ã«çšããããšãã§ã
ãã The crude L-alanine solution used in the present invention can be obtained, for example, as described above, by a known method of reacting with an immobilized enzyme using fumaric acid and ammonia as substrates. For example, microbial cells having aspartase activity or a processed product thereof and microbial cells having L-aspartate-β-decarboxylase activity or a processed product thereof are collected using known methods (e.g., carrageenan gel entrapment method, polyacrylamide gel entrapment method, etc.). It can be easily produced by carrying out an enzymatic reaction using an immobilized product obtained by immobilization using a method such as a method. As the microorganism having aspartase activity, any microorganism having this activity can be used, such as Escherichia coli (ATCC-11303), and as the microorganism having L-aspartate-β-decarboxylase activity, Any active substance can be used, and for example, Pseudomonas dacne (IAM-1152) can be suitably used.
äžèšã®åŠãé
µçŽ åå¿ã«ããåŸãããç²ïŒ¬âã¢ã©
ãã³æº¶æ¶²äžã«ååšãããã¢ã«ã«ãªéå±ãšããŠã¯ã
äŸãã°ãããªãŠã ãã«ãªãŠã ã®åŠãã¢ã«ã«ãªéå±
ã奜é©ã«æãããããããã¯äŸãã°æ°Žé
žåãããª
ãŠã ãæ°Žé
žåã«ãªãŠã ã®åŠãæ°Žé
žåã¢ã«ã«ãªé
å±ãçé
žãããªãŠã ãçé
žã«ãªãŠã ã®åŠãã¢ã«ã«
ãªéå±çé
žå¡©ãããã¯çé
žæ°ŽçŽ ãããªãŠã ãçé
ž
æ°ŽçŽ ã«ãªãŠã ã®åŠãã¢ã«ã«ãªéå±çé
žæ°ŽçŽ å¡©ãšã
ãŠäŸçµŠããã®ã奜ãŸããã該ã¢ã«ã«ãªéå±ã®æ·»å
éã¯ç²ïŒ¬âã¢ã©ãã³æº¶æ¶²äžã«å
±åãã借éç©ãã
ãªãã¡ãããã«é
žãâãªã³ãŽé
žãâã¢ã¹ãã©
ã®ã³é
žã®ç·éã«å¯ŸããŠ0.5åœé以äžã奜ãŸããã¯
ïŒã1.5åœéã§ããã®ã奜ãŸããããããã¢ã«ã«
ãªéå±ååç©ã¯ãé
µçŽ åå¿çµäºåŸã®ç²ïŒ¬âã¢ã©ã
ã³æº¶æ¶²äžãžæ·»å ããã®ãè¯ãããåºè³ªèª¿è£œæãã
ãã¯ïŒ¬âã¢ã¹ãã©ã®ã³é
žãžã®è»¢æé
µçŽ åå¿çµäºæ
ã«ãããããããã®éã«å¿ãæ·»å ããŠãããããŸ
ããåºè³ªèª¿è£œæã«æ·»å ããå Žåã¯ããã«é
žãããª
ãŠã ãããã«é
žã«ãªãŠã ã®åŠãããã«é
žã¢ã«ã«ãª
éå±å¡©ã®åœ¢ã§ãâã¢ã¹ãã©ã®ã³é
žãžã®è»¢æé
µçŽ
åå¿çµäºæã«æ·»å ããå Žåã¯ãâã¢ã¹ãã©ã®ã³
é
žãããªãŠã ãâã¢ã¹ãã©ã®ã³é
žã«ãªãŠã ã®åŠ
ãâã¢ã¹ãã©ã®ã³é
žã¢ã«ã«ãªéå±å¡©ã®åœ¢ã§äŸçµŠ
ããããšãã§ããã The alkali metals present in the crude L-alanine solution obtained by the above enzymatic reaction are as follows:
For example, alkali metals such as sodium and potassium are preferably mentioned, and these include, for example, alkali metal hydroxides such as sodium hydroxide and potassium hydroxide, alkali metal carbonates such as sodium carbonate and potassium carbonate, and sodium hydrogen carbonate and potassium hydrogen carbonate. Preferably, it is supplied as an alkali metal bicarbonate such as. The amount of the alkali metal added is 0.5 equivalent or more, preferably 1 to 1.5 equivalent, based on the total amount of impurities coexisting in the crude L-alanine solution, that is, fumaric acid, L-malic acid, and L-aspartic acid. is preferable. These alkali metal compounds are preferably added to the crude L-alanine solution after the enzymatic reaction, but they may also be added in advance according to the amount when preparing the substrate or at the end of the converting enzyme reaction to L-aspartic acid. good. When added at the time of substrate preparation, it is in the form of an alkali metal salt of fumarate such as sodium fumarate and potassium fumarate, and when added at the end of the conversion enzyme reaction to L-aspartic acid, it is added in the form of sodium L-aspartate, L-aspartate, etc. - It can also be supplied in the form of an alkali metal salt of L-aspartate, such as potassium aspartate.
ã¢ã«ã«ãªéå±ãååšãããç²ïŒ¬âã¢ã©ãã³æº¶æ¶²
ããâã¢ã©ãã³çµæ¶ãååŸããã«åœã€ãŠã¯ãäŸ
ãã°è©²æº¶æ¶²ã掻æ§çåŠçããã®ã¡æ¿çž®ãã次ãã§
âã¢ã©ãã³çµæ¶ãæ¶æãããããšã«ããè¡ãªã
ããšãã§ããã In obtaining L-alanine crystals from a crude L-alanine solution in the presence of an alkali metal, it can be carried out, for example, by treating the solution with activated carbon, concentrating it, and then crystallizing L-alanine crystals. .
掻æ§çåŠçã¯ã溶液äžã«å«ãŸããåºäœç²åã埮
çç©èäœã«ç±æ¥ããçºç±æ§ç©è³ªïŒãã€ããžãšã³ïŒ
ãé€å»ãããã®ã§ããããã®æäœãå¹çããè¡ãª
ãããã«ã¯ãå æž©äžïŒçŽ80âãçŽ60âïŒã§è¡ãªã
ã®ã奜ãŸãããåŠçæéã¯ãçŽ10ã20åéã§å
å
ã§ããããã®æŽ»æ§çåŠçã¯ãç²ïŒ¬âã¢ã©ãã³æº¶æ¶²
ã«çŽæ¥å®æœããŠãããããæåã«ïŒ¬âã¢ã©ãã³æº¶
液ãããçšåºŠæ¿çž®ããåŸã«è¡ãªã€ãŠãããã Activated carbon treatment removes pyrogenic substances (pyrogienes) derived from solid particles and microbial cells contained in the solution.
In order to perform this operation efficiently, it is preferable to carry out the operation under heating (about 80°C to about 60°C). A treatment time of approximately 10 to 20 minutes is sufficient. This activated carbon treatment may be carried out directly on the crude L-alanine solution, or may be carried out after first concentrating the L-alanine solution to some extent.
æ¿çž®æäœã¯æº¶æ¶²äžã«å«ãŸããã¢ã³ã¢ãã¢ã®é€å»
ãç®çãšãããã®ã§ããã該æ¿çž®æäœã¯ïŒ¬âã¢ã©
ãã³ã®ã©ã»ãåãå解ãé¿ããããæ¯èŒçäœæž©
ïŒçŽ80â以äžã奜ãŸããã¯çŽ60â以äžïŒã§æžå§ç¶
æ
ã§è¡ãªãã®ã奜ãŸãããå°ãã¢ã«ã«ãªéå±ãå
åšãããŠæ¿çž®ããæ¬çºææ¹æ³ã«ããã°ã溶液ãã¢
ã«ã«ãªæ§ãšãªã€ãŠããããã溶液äžã«å«æãããŠ
ããã¢ã³ã¢ããŠã ã€ãªã³ïŒNH4 +ïŒã¯æº¶åã¢ã³ã¢
ãã¢ïŒNH3ïŒã®åœ¢ã«å€æããããã®æ¿çž®æäœã«
ãããŠã¢ã³ã¢ãã¢ã®é€å»ãå¹çè¯ãè¡ãªããã The purpose of the concentration operation is to remove ammonia contained in the solution, and the concentration operation is performed at a relatively low temperature (approximately 80°C or lower, preferably approximately 60°C or lower) to avoid racemization or decomposition of L-alanine. It is preferable to carry out the process under reduced pressure. In addition, according to the present invention method of concentration in the presence of an alkali metal, since the solution is alkaline, ammonium ions (NH 4 + ) contained in the solution are converted into dissolved ammonia (NH 3 ). Ammonia can be efficiently removed in this concentration operation.
äžèšã®åŠãæ¿çž®æäœãä»ããâã¢ã©ãã³æº¶æ¶²
ããâã¢ã©ãã³çµæ¶ãæ¶æãããã«ã¯ã該溶液
ãæŽã«æ¿çž®ãããããããã¯å·åŽãããåã¯ã¡ã¿
ããŒã«ããšã¿ããŒã«ã®åŠãæ°Žæ§æº¶åªãæ·»å ãããª
ã©ã«ãã容æã«å®æœã§ããããããã®æäœã¯ãã¢
ããé
žã®æ¶æã«éåžžçšããããæ¹æ³ã«ãã€ãŠè¡ãª
ãããšãã§ãããå°ãæ¶ææäœæã®æ¶²æ§ã¯ãç®ç
ç©ã®åçã«åœ±é¿ãäžãããããå¿
èŠãªãã°æ¶æç³»
ã®æ¶²æ§ãPH5.0ã9.0ã奜ãŸããã¯6.0ã8.0ã«èª¿æŽ
ããŠæ¶æããã®ã奜ãŸãããPH調æŽã«ã¯ãå¡©é
žã
é
¢é
žãç¡«é
žããªã©ã䜿çšããããšãã§ããã In order to crystallize L-alanine crystals from the L-alanine solution subjected to the concentration operation as described above, it is easy to further concentrate the solution, cool it, or add an aqueous solvent such as methanol or ethanol. It can be implemented. These operations can be performed by methods commonly used for crystallizing amino acids. In addition, since the liquid property during the crystallization operation affects the yield of the target product, if necessary, adjust the liquid property of the crystallization system to PH5.0 to 9.0, preferably 6.0 to 8.0 for crystallization. is preferable. To adjust the pH, use hydrochloric acid,
Acetic acid, sulfuric acid, etc. can be used.
äžèšã®åŠãæ¬çºææ¹æ³ã«ããã°ãããã«é
žã
âãªã³ãŽé
žãâã¢ã¹ãã©ã®ã³é
žãªã©ã®å€Ÿéç©ã
å«ãŸãããŸããã€ããžãšã³ã®æ··å
¥ãèªããããæŽ
ã«ãã¢ã³ã¢ããŠã å«éã®äœã極ããŠé«çŽåºŠã®ïŒ¬â
ã¢ã©ãã³çµæ¶ããåçµæ¶æäœãã€ãªã³äº€ææš¹èåŠ
çãªã©ã®ç
©éãªæäœãè¡ãªãããšãªããéåžžã«ç°¡
䟿ãªæäœã§åçè¯ãåŸãããšãã§ãããå°ãæ¬çº
ææ¹æ³ã§åŸãããâã¢ã©ãã³çµæ¶ã¯åè¿°ã®åŠã
借éç©ããã€ããžãšã³ãå«ãã§ããªãã®ã§ãã®ãŸ
ãŸå»ççšïŒäŸãã°èŒžæ¶²çšåæ«ïŒãšããŠäœ¿çšã§ã
ãã According to the method of the present invention as described above, fumaric acid, L
- Contains no impurities such as malic acid or L-aspartic acid, and no pyrodiene contamination.Furthermore, extremely high purity L- with low ammonium content.
Alanine crystals can be obtained in high yield with a very simple operation without complicated operations such as recrystallization or ion exchange resin treatment. As mentioned above, the L-alanine crystals obtained by the method of the present invention do not contain impurities or pyrodiene, so they can be used as they are for medical purposes (for example, as bulk powder for infusions).
åŸã€ãŠæ¬çºææ¹æ³ã¯ïŒ¬âã¢ã©ãã³é«çŽåºŠçµæ¶ã®
å·¥æ¥ç補æ³ãšããŠåªããæ¹æ³ã§ããã Therefore, the method of the present invention is an excellent method for industrially producing high-purity crystals of L-alanine.
以äžã«å®æœäŸãæããŠæŽã«æ¬çºæã詳ãã説æ
ããã The present invention will be further explained in detail with reference to Examples below.
å®æœäŸ ïŒ
åŸè¿°ã®åèäŸïŒã§åŸãããâã¢ã©ãã³æº¶æ¶²
ïŒïŒ¬âã¢ã©ãã³1.4ã¢ã«ãããã«é
ž28ããªã¢ã«ã
âãªã³ãŽé
ž52ããªã¢ã«ãâã¢ã¹ãã©ã®ã³é
ž15ã
ãªã¢ã«ããã³çé
žã¢ã³ã¢ããŠã ãå«æïŒïŒã«ã
æ°Žé
žåã«ãªãŠã 170ããªã¢ã«ããã³æŽ»æ§çãéªïŒ¡ã
ïŒè€æ²¢è¬åå·¥æ¥æ ªåŒäŒç€Ÿè£œã®æŽ»æ§çïŒïŒïœãæ·»å
ãã60âã§20åéå ç±ããåŸã掻æ§çãåé¢ã
ããã液ãæžå§æ¿çž®ãã液éãçŽ180mlãšããåŸã
15âã«å·åŽããïŒè©²äŸåŽæ¶²ã®PHïŒ8.0ïŒãæåºçµæ¶
ããåããå°éã®å«æ°Žã¡ã¿ããŒã«ã«ãŠæŽæµåŸä¹Ÿç¥
ããããšã«ããâã¢ã©ãã³çµæ¶114.9ïœãåŸãã
åç92.1ïŒ
ãαã20 DïŒ14.8°ïŒïŒ£ïŒ10ã6NâHClïŒ
ããã«é
žïŒæ³šïŒïŒïŒæ€åºããã
âãªã³ãŽé
žïŒæ³šïŒïŒïŒæ€åºããã
âã¢ã¹ãã©ã®ã³é
žïŒæ³šïŒïŒïŒæ€åºããã
çºç±æ§ç©è³ªïŒæ³šïŒïŒïŒèªããïŒ0.05°ã0.10°ã
0.15°ïŒ
ã¢ã³ã¢ããŠã å«éïŒæ³šïŒïŒïŒ9ppm
泚ïŒïŒçŽ°ç®¡åŒçéé»æ°æ³³ååææ³ïŒå³¶æŽ¥è£œ1Pâ
2AåïŒã«ããåæãæ€åºéç0.01ïŒ
泚ïŒïŒé«é液äœã¯ãããã°ã©ãã«ããåæãæ€åº
éç0.005ïŒ
泚ïŒïŒå®¶å
æ³ã«ããâã¢ã©ãã³ïŒïŒ
溶液ã10
mgïŒKgã®æ¡ä»¶ã§å®æœãä»ã®æ¡ä»¶ã¯ãæ¥æ¬è¬å±æ¹
第10çãã«æºæ ãããExample 1 L-alanine solution obtained in Reference Example 2 (L-alanine 1.4 mol, fumaric acid 28 mmol, L
- containing 52 mmol of malic acid, 15 mmol of L-aspartic acid and ammonium carbonate) 1,
170 mmol of potassium hydroxide and activated carbon "Snow A"
After adding 2 g of activated carbon (manufactured by Fujisawa Pharmaceutical Co., Ltd.) and heating at 60°C for 20 minutes, the activated carbon is separated. After concentrating the filtrate under reduced pressure to a liquid volume of approximately 180 ml,
Cool to 15°C (PH of the coolant: 8.0). The precipitated crystals were collected by filtration, washed with a small amount of water-containing methanol, and then dried to obtain 114.9 g of L-alanine crystals.
Yield 92.1% [α] 20 D +14.8° (C = 10, 6N-HCl) Fumaric acid (Note 1); Not detected, L-malic acid (Note 1); Not detected, L-Aspartic acid (Note 2); Not detected and pyrogen (Note 3); Not recognized (0.05°, 0.10°,
0.15°) Ammonium content (Note 4); 9ppm Note 1: Capillary isotachophoresis analysis method (Shimadzu 1P-
Type 2A). Detection limit 0.01% Note 2: Analyzed by high performance liquid chromatography. Detection limit 0.005% Note 3: 10% L-alanine 5% solution by rabbit method
Conducted under mg/Kg conditions. Other conditions were based on the 10th edition of the Japanese Pharmacopoeia.
泚ïŒïŒã€ã³ãããšããŒã«æ³ã«ããåæãNote 4: Analyzed by indophenol method.
å®æœäŸ ïŒ
åŸè¿°ã®åèäŸïŒã§åŸãããâã¢ã©ãã³æº¶æ¶²
ïŒïŒ¬âã¢ã©ãã³1.41ã¢ã«ãããã«é
ž29ããªã¢ã«ã
âãªã³ãŽé
ž53ããªã¢ã«ãâã¢ã¹ãã©ã®ã³é
žïŒ
ããªã¢ã«ããã³çé
žã¢ã³ã¢ããŠã å«æïŒïŒã«æ°Ž
é
žåã«ãªãŠã 0.2ã¢ã«ãå ãã以äžå®æœäŸïŒãšå
æ¡ä»¶ã§æŽ»æ§çåŠçããã³æžå§æ¿çž®ãè¡ãªããå
šé
çŽ200mlãšããåŸã15âã«å·åŽãããïŒè©²å·åŽæ¶²ã®
PH9.6ïŒã次ã«æ¿å¡©é
žã§æº¶æ¶²ã®PHã7.6ã«èª¿ç¯ãæŽ
ã«çŽïŒæéé眮ãããæåºçµæ¶ããåãå°éã®å«
æ°Žã¡ã¿ããŒã«ã§æŽæµåŸä¹Ÿç¥ããããšã«ããâã¢
ã©ãã³çµæ¶113.7ïœãåŸããåç90.5ïŒ
ãαã20 DïŒ14.8°ïŒïŒ£ïŒ10ã6NâHClïŒ
ããã«é
žïŒæ€åºããã
âãªã³ãŽé
žïŒæ€åºããã
âã¢ã¹ãã©ã®ã³é
žïŒæ€åºããã
çºç±æ§ç©è³ªïŒèªããïŒ0.20°ã0.15°ã0.10°ïŒ
ã¢ã³ã¢ããŠã å«éïŒ11ppm
å®æœäŸ ïŒ
åºè³ªæº¶æ¶²ãšããŠ10-3Mã®å¡©åãã°ãã·ãŠã ãã
ã³0.08Mã®ããã«é
žãžã«ãªãŠã ãå«ã1.25Mãã
ã«é
žã¢ã³ã¢ããŠã 氎溶液ãçšãåŸè¿°ã®åèäŸïŒâ
(3)ãšåæ§ã«ããŠé
µçŽ åå¿ãè¡ãªããâã¢ã©ãã³
溶液ïŒïŒ¬âã¢ã©ãã³1.26ã¢ã«ïŒãããã«é
ž13.5
ããªã¢ã«ïŒãâãªã³ãŽé
ž49.4ããªã¢ã«ïŒã
âã¢ã¹ãã©ã®ã³é
ž1.5ããªã¢ã«ïŒããã³çé
ž
ã¢ã³ã¢ããŠã ãå«æïŒãåŸãã該âã¢ã©ãã³æº¶
液2.2ã«æŽ»æ§çãéªïŒ¡ãïŒïœãæ·»å ãã80âã§
10åéå ç±ããåŸæŽ»æ§çãåé¢ãããã液ãæžå§
æ¿çž®ãå
šéãçŽ280mlãšããåŸ15âã«å·åŽãã
ïŒè©²å·åŽæ¶²ã®PHïŒ9.0ïŒãæåºçµæ¶ããåããå°é
ã®å«æ°Žã¡ã¿ããŒã«ã§æŽæµåŸä¹Ÿç¥ããããšã«ããã
âã¢ã©ãã³çµæ¶228.7ïœãåŸããåç92.4ïŒ
ãαã20 DïŒ14.8°ïŒïŒ£ïŒ10ã6NâHClïŒ
ããã«é
žïŒæ€åºããã
âãªã³ãŽé
žïŒæ€åºããã
âã¢ã¹ãã©ã®ã³é
žïŒæ€åºããã
çºç±æ§ç©è³ªïŒèªããïŒ0.10°ã0.20°ã0.00°ïŒ
ã¢ã³ã¢ããŠã å«éïŒ10ppm
åèäŸ ïŒ
ã¢ã«ã«ãªéå±ã䜿çšããªãäŸã§ãåŸãããç®ç
ç©ã®çŽåºŠã倧ãã圱é¿ãããããšã瀺ããExample 2 L-alanine solution obtained in Reference Example 2 (L-alanine 1.41 mol, fumaric acid 29 mmol,
L-malic acid 53 mmol, L-aspartic acid 2
0.2 mol of potassium hydroxide was added to 1 (containing mmol and ammonium carbonate), treated with activated carbon and concentrated under reduced pressure under the same conditions as in Example 1 to a total volume of about 200 ml, and then cooled to 15°C. (of the cooling liquid)
PH9.6). Next, adjust the pH of the solution to 7.6 with concentrated hydrochloric acid, and let it stand for about 1 hour. The precipitated crystals were collected by filtration, washed with a small amount of water-containing methanol, and then dried to obtain 113.7 g of L-alanine crystals. Yield 90.5% [α] 20 D +14.8° (C = 10, 6N-HCl) Fumaric acid: not detected L-malic acid: not detected L-aspartic acid: not detected Pyrogen; not recognized (0.20°, 0.15°, 0.10°) Ammonium content: 11 ppm Example 3 Reference Example 2 described later using a 1.25 M ammonium fumarate aqueous solution containing 10 -3 M magnesium chloride and 0.08 M dipotassium fumarate as a substrate solution.
An enzymatic reaction was carried out in the same manner as in (3), and L-alanine solution (1.26 mol/L-alanine, 13.5 mol/fumaric acid) was prepared.
mmol/, L-malic acid 49.4 mmol/,
1.5 mmol of L-aspartic acid/containing ammonium carbonate) is obtained. Add 4 g of activated carbon "Yuki A" to 2.2 of the L-alanine solution and heat at 80°C.
Separate the activated carbon after heating for 10 minutes. The filtrate is concentrated under reduced pressure to a total volume of about 280 ml, and then cooled to 15°C (PH of the cooling liquid: 9.0). By filtering the precipitated crystals, washing them with a small amount of water-containing methanol, and drying them,
228.7 g of L-alanine crystals are obtained. Yield 92.4% [α] 20 D +14.8° (C = 10, 6N-HCl) Fumaric acid: not detected L-malic acid: not detected L-aspartic acid: not detected Pyrogen; not recognized (0.10°, 0.20°, 0.00°) Ammonium content: 10ppm Reference example 1 An example in which no alkali metal is used, showing that the purity of the obtained target product is greatly affected.
å®æœäŸïŒã§äœ¿çšãããã®ãšåæ§ã®ïŒ¬âã¢ã©ãã³
溶液ïŒã«æŽ»æ§çãéªïŒ¡ãïŒïœãæ·»å ãã60âã§
20åéå ç±ããåŸæŽ»æ§çãåé¢ãããã液ãæžå§
æ¿çž®ãå
šéãçŽ200mlãšããåŸ15âã«å·åŽãã
ïŒè©²å·åŽæ¶²ã®PHïŒ5.6ïŒãæåºçµæ¶ããåãå°éã®
å«æ°Žã¡ã¿ããŒã«ã§æŽæµåŸä¹Ÿç¥ããããšã«ããã
âã¢ã©ãã³çµæ¶110.6ïœãåŸããåç88.7ïŒ
ãαã20 DïŒ14.7°ïŒïŒ£ïŒ10ã6NâHClïŒ
ããã«é
žïŒ0.04ïŒ
âãªã³ãŽé
žïŒ0.02ïŒ
âã¢ã¹ãã©ã®ã³é
žïŒ0.013ïŒ
ã¢ã³ã¢ããŠã å«éïŒ164ppm
æ¬åã¯ãæ¬çºææ¹æ³ã«ããåŸãããçµæ¶ã«æ¯
ã¹ã借éç©ã®æ··å
¥ãããããããã¢ã³ã¢ããŠã å«
éã¯çŽ10å以äžé«ãã 2 g of activated carbon "Yuki A" was added to L-alanine solution 1 similar to that used in Example 1, and the mixture was heated at 60°C.
Separate the activated carbon after heating for 20 minutes. The filtrate is concentrated under reduced pressure to a total volume of about 200 ml, and then cooled to 15°C (PH of the cooling liquid: 5.6). By filtering the precipitated crystals, washing them with a small amount of water-containing methanol, and drying them, L
- Obtain 110.6 g of alanine crystals. Yield 88.7% [α] 20 D +14.7° (C = 10, 6N-HCl) Fumaric acid; 0.04% L-malic acid; 0.02% L-aspartic acid; 0.013% Ammonium content: 164 ppm This product is Compared to the crystals obtained by the invention method, there is contamination and the ammonium content is about 10 times higher.
åèäŸ ïŒ
ïŒåºå®åèäœãçšããâã¢ã©ãã³ã®è£œé ïŒ
(1) ã¢ã¹ãã«ã¿ãŒãŒæŽ»æ§ãæããåºå®åèäœã®èª¿
補
ã³ãŒã³ã¹ããŒããªã«ãŒïŒïŒ
ãããŒã¹ãïŒïŒ
ã
ããã«é
ž1.14ïŒ
ãããã«é
žãžã¢ã³ã¢ããŠã 0.5
ïŒ
ã第äžãªã³é
žã«ãªãŠã 0.2ïŒ
ããã³ç¡«é
žãã°
ãã·ãŠã 0.05ïŒ
ãå«ãå¹å°ïŒPH7.0ïŒ100mlã
500ml容åå£ãã©ã¹ã³ã«å
¥ããããã«ãšã·ãšãª
ã·ã¢ã»ã³ãªïŒATCCâ11303ïŒãæ€èããã30
âã§16æéæ¯ãšãå¹é€ããåŸãé å¿åé¢ããã
ãšã«ãããšã·ãšãªã·ã¢ã»ã³ãªèäœ23ïœïŒæ¹¿é
éïŒãåŸããReference Example 2 (Production of L-alanine using immobilized bacterial cells) (1) Preparation of immobilized bacterial cells having aspartase activity Corn steep liquor 2%, meat 2%,
Fumaric acid 1.14%, diammonium fumarate 0.5
%, 100 ml of medium (PH7.0) containing monopotassium phosphate 0.2% and magnesium sulfate 0.05%.
Pour into a 500 ml Sakaguchi flask and inoculate it with Escherichia coli (ATCC-11303). 30
After culturing with shaking at â for 16 hours, 23 g (wet weight) of E. coli cells were obtained by centrifugation.
å¥ã«ã²ããŠãŒã²ã«WGïŒã³ãã³ããŒã²ã³ãã¯
ãã³ãã¢ã¯ããªãŒç€Ÿè£œã®ã«ã©ã®ãŒãã³ïŒïŒïœã
45âã®æž©æ°Ž129mlã«æº¶è§£ãã«ã©ã®ãŒãã³æ°Žæº¶æ¶²
ã調補ãããã®æº¶æ¶²ã«äžèšã§åŸããšã·ãšãªã·
ã¢ã»ã³ãªèäœ23ïœãççé£å¡©æ°Ž23mlã«ããæ¿ã
ããã®ã40âã«ãŠæ·»å æ··åãããæ··å液ãïŒâ
ã«å·åŽã30åæŸçœ®ãçæããã²ã«ãïŒèŸºãçŽïŒ
mmã®ç«æ¹äœã«æåãããåŸãããæåã²ã«ã
âã¢ã¹ãã©ã®ã³é
ž10ããªã¢ã«ããã³å¡©åã«ãªãŠ
ã ïŒïŒ
ãå«ã氎溶液400mläžã«æµžæŒ¬ã37âã§24
æéæŸçœ®ãããçæã²ã«ãåé¢ãïŒïŒ
å¡©åã«ãª
ãŠã 氎溶液ã§æŽæµããããšã«ããåºå®åãšã·ãš
ãªã·ã¢ã»ã³ãªèäœ180ïœïŒæµžééïŒãåŸãã Separately, add 6 g of Genyugel WG (carrageenan manufactured by Copenhagen Pectin Factory).
A carrageenan aqueous solution is prepared by dissolving it in 129 ml of warm water at 45°C, and 23 g of E. coli cells obtained above suspended in 23 ml of physiological saline are added to this solution and mixed at 40°C. Mixed liquid at 4â
Cool it to 30 minutes and leave it for 30 minutes.
Form into a mm cube. The obtained molded gel is
- immersed in 400 ml of an aqueous solution containing 10 mmol of aspartic acid and 2% potassium chloride at 37°C for 24 hours.
Leave it for a while. The resulting gel was separated and washed with a 2% potassium chloride aqueous solution to obtain 180 g (immersion weight) of immobilized E. coli cells.
(2) âã¢ã¹ãã©ã®ã³é
žâβâãã«ã«ããã·ã©ãŒ
ãŒæŽ»æ§ãæããåºå®åèäœã®èª¿è£œ
ã°ã«ã¿ãã³é
žãããªãŠã 3.2ïŒ
ãããŒã¹ã0.5
ïŒ
ã第äžãªã³é
žã«ãªãŠã 0.05ïŒ
ããã³ç¡«é
žãã°
ãã·ãŠã 0.01ïŒ
ãå«ãå¹å°ïŒPH7.3ïŒã500ml容
åå£ãã©ã¹ã³ã«ïŒæ¬åœã120mlã¥ã€10æ¬ã«å
¥ãã
ããã«ã·ãšãŒãã¢ãã¹ã»ãã¯ããŒïŒIAMâ
1152ïŒãæ€èããã30âã§24æéæ¯ãšãå¹é€ã
ãåŸãé å¿åé¢ããããšã«ããã·ãŠãŒãã¢ã
ã¹ã»ãã¯ããŒèäœ20ïœïŒæ¹¿ééïŒãåŸãã(2) Preparation of immobilized bacterial cells having L-aspartate-β-decarboxylase activity Sodium glutamate 3.2%, Meast 0.5
%, monobasic potassium phosphate 0.05%, and magnesium sulfate 0.01% (PH7.3) into 10 500 ml Sakaguchi flasks, 120 ml each.
This is combined with Syedomonas dacne (IAM-
1152). After culturing with shaking at 30°C for 24 hours, 20 g (wet weight) of Pseudomonas dacne cells were obtained by centrifugation.
å¥ã«ã²ããŠãŒã²ã«WG4.03ïœã50âã®æž©æ°Ž85
mlã«æº¶è§£ãã«ã©ã®ãŒãã³æ°Žæº¶æ¶²ã調補ãããã®
溶液ã«äžèšã§åŸãã·ãŠãŒãã¢ãã¹ã»ãã¯ããŒè
äœ20ïœãççé£å¡©æ°Ž20mlã«ããæ¿ãããã®ã45
âã«ãŠæ·»å æ··åãããæ··å液ãïŒâã«å·åŽã30
åæŸçœ®ãçæããã²ã«ãïŒèŸºãçŽïŒmmã®ç«æ¹äœ
ã«æåããããšã«ããåºå®åã·ãŠãŒãã¢ãã¹ã»
ãã¯ããŒèäœ130ïœïŒæµžééïŒãåŸãã Separately, add Genyugel WG 4.03g to 50â warm water 85
Prepare a carrageenan aqueous solution by dissolving 20 g of the Pseudomonas dacne cells obtained above in 20 ml of physiological saline.
Add and mix at â. Cool the mixture to 4°C
Immobilized Pseudomonas by molding the resulting gel into a cube with a side of approximately 3 mm.
Obtain 130 g (soaked weight) of Daknei bacterial cells.
(3) é
µçŽ åå¿
(1)ã§åŸãåºå®åèäœ40ïœãå€ãšã管ä»ã«ã©ã
ïŒå
åŸ1.6cmãé·ã19cmïŒã«å
å¡«ãããããã«ã
10-3Mã®å¡©åãã°ãã·ãŠã ãå«ã1.5Mããã«
é
žã¢ã³ã¢ããŠã 氎溶液ïŒ1.5Mã®ããã«é
žãšã¢
ã³ã¢ãã¢ã§PH8.5ã®æº¶æ¶²ã調æŽïŒã37âã«ãŠ20
mlïŒhrã®æµéã§å°éããããã®æµåºæ¶²ã«ïŒ¬âã¢
ã¹ãã©ã®ã³é
žçµæ¶ãæ·»å ããããšã«ããPH6.0
ã6.5ã«èª¿è£œãã該溶液ã«10-4Mã®ããªãããµ
ãŒã«ãªã³é
žãæ·»å ããããã®æº¶æ¶²ã(2)ã§åŸãåº
å®åèäœ120ïœãå
å¡«ãããå€ãšã管ä»ã«ã©ã
ïŒå
åŸ2.1cmãé·ã34.8cmïŒã®äžéšãã37âã«ãŠ
äžåã«åã€ãŠ20mlïŒhrã®æµéã§å°éãããæµåº
液ãéããããšã«ããâã¢ã©ãã³å«æé
µçŽ å
å¿çµäºæ¶²ãåŸãã(3) Enzyme reaction Pack 40 g of the immobilized bacterial cells obtained in (1) into a column with an outer shell (inner diameter 1.6 cm, length 19 cm). to this,
A 1.5M ammonium fumarate aqueous solution containing 10 -3 M magnesium chloride (pH 8.5 solution prepared with 1.5M fumaric acid and ammonia) was heated at 37â for 20 minutes.
Conduction was conducted at a flow rate of ml/hr. By adding L-aspartic acid crystals to this effluent, pH6.0 was achieved.
6.5 and add 10 â4 M pyridoxal phosphate to the solution. This solution was poured upward at 37°C from the bottom of a column with an outer jacket tube (inner diameter 2.1 cm, length 34.8 cm) filled with 120 g of the immobilized bacterial cells obtained in (2) at a flow rate of 20 ml/hr. Conduct. By collecting the effluent, an L-alanine-containing enzyme reaction completed solution is obtained.
Claims (1)
ã³é žã®åã¢ã³ã¢ããŠã å¡©ã借éç©ãšããŠå«æãã
ç²ïŒ¬âã¢ã©ãã³æº¶æ¶²ããâã¢ã©ãã³çµæ¶ãååŸ
ããã«éãã該ç²ïŒ¬âã¢ã©ãã³æº¶æ¶²äžã«å ±åãã
ããã«é žãâãªã³ãŽé žåã³ïŒ¬âã¢ã¹ãã©ã®ã³é ž
ã®ç·éã«å¯ŸãçŽ0.5ã1.5åœéã®ã¢ã«ã«ãªéå±ãå
åšãããŠæ¿çž®ããåŸãæ¶æãè¡ãããšãç¹åŸŽãšã
ãé«çŽåºŠïŒ¬âã¢ã©ãã³çµæ¶ã®ååŸæ¹æ³ã1. When obtaining L-alanine crystals from a crude L-alanine solution containing ammonium salts of fumaric acid, L-malic acid, and L-aspartic acid as impurities, fumaric acid coexisting in the crude L-alanine solution , L-malic acid and L-aspartic acid are concentrated in the presence of about 0.5 to 1.5 equivalents of an alkali metal relative to the total amount, and then crystallized.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12059483A JPS6012994A (en) | 1983-07-01 | 1983-07-01 | Preparation of l-alanine crystal |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12059483A JPS6012994A (en) | 1983-07-01 | 1983-07-01 | Preparation of l-alanine crystal |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6012994A JPS6012994A (en) | 1985-01-23 |
JPH0379990B2 true JPH0379990B2 (en) | 1991-12-20 |
Family
ID=14790123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP12059483A Granted JPS6012994A (en) | 1983-07-01 | 1983-07-01 | Preparation of l-alanine crystal |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6012994A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5327792A (en) * | 1976-08-25 | 1978-03-15 | Hitachi Ltd | Fuel and control rod supporter |
JPS568691A (en) * | 1979-07-03 | 1981-01-29 | Denki Kagaku Kogyo Kk | Method and apparatus for continuous production of l-alanine |
JPS5783289A (en) * | 1980-09-17 | 1982-05-25 | Grace W R & Co | Preparation of l-alanine by using fixed microorganism |
-
1983
- 1983-07-01 JP JP12059483A patent/JPS6012994A/en active Granted
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5327792A (en) * | 1976-08-25 | 1978-03-15 | Hitachi Ltd | Fuel and control rod supporter |
JPS568691A (en) * | 1979-07-03 | 1981-01-29 | Denki Kagaku Kogyo Kk | Method and apparatus for continuous production of l-alanine |
JPS5783289A (en) * | 1980-09-17 | 1982-05-25 | Grace W R & Co | Preparation of l-alanine by using fixed microorganism |
Also Published As
Publication number | Publication date |
---|---|
JPS6012994A (en) | 1985-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK148018B (en) | METHOD FOR PREPARING L-PHENYLGYLINE AND D-PHENYLGLYCINAMIDE OR D-PHENYLGYLINE | |
JPS6231913B2 (en) | ||
NL8304496A (en) | METHOD FOR INSULATING L-AMINO ACIDS | |
JP4361641B2 (en) | Separation and recovery method of optically active amino acid and optically active amino acid amide | |
JPH0379990B2 (en) | ||
JPS60217897A (en) | Method for separating and purifying lactic acid | |
JPS59118735A (en) | Manufacture of pure aqueous solution of l-malic acid | |
JP4548756B2 (en) | Purification method of amino acid amide | |
JP3014194B2 (en) | Isolation of tryptophan | |
JP2804005B2 (en) | Method for producing L-aspartic acid | |
JPH0229075B2 (en) | TORIPUTOFUANNOSHOSEKIHO | |
JP2804004B2 (en) | Method for producing L-aspartic acid | |
JP2951785B2 (en) | Crystallization method of L-phenylalanine | |
CN105506016A (en) | Method for producing DL-aspartic acid by adopting enzyme method | |
KR860001821B1 (en) | Method of isolating l-amino acids | |
JPH0471906B2 (en) | ||
JP3776160B2 (en) | Method for producing D-calcium pantothenate | |
JP3704770B2 (en) | Method for producing L-aspartic acid | |
JPH10337195A (en) | Production of aqueous solution of l-aspartic acid alkali or alkaline earth metal salt | |
JP2575403B2 (en) | Method for producing L-tryptophan | |
JPH0545236B2 (en) | ||
JPS6225353B2 (en) | ||
JPH09163993A (en) | Production of l-aspartic acid | |
JP2000169434A (en) | Production of (s,s)-dialkylenediamine-n,n'-disuccinic acid | |
JPH0489479A (en) | Recovery of optically active tryptophan |